It is very difficult to develop specific therapies for very rare forms of muscular dystrophy such as oculopharyngeal muscular dystrophy (OPMD). However, potential therapeutics in development for other muscular dystrophies (if successful) also may be effective for these diseases.
Some strategies, such as muscle strengthening drugs or stem cell therapies, may be effective in many muscular dystrophies. MDA also has supported researchers who have worked out the genetic causes of OPMD, and this is a starting point for more specific therapies.
Muscular Dystrophy Association — USA
222 S. Riverside Plaza, Suite 1500
Chicago, Illinois 60606
The Muscular Dystrophy Association (MDA) is a qualified 501(c)(3) tax-exempt organization.
©2015, Muscular Dystrophy Association Inc. All rights reserved.